Missouri House Approves Measure Requiring State to Conduct Psilocybin Mental Health Studies

April 5, 2023 · Ganjapreneur

The Missouri House last week approved a measure that would require the state to conduct studies on psilocybin to treat depression, substance abuse, post-traumatic stress disorder, or use as part of end-of-life care, the Missouri Independent reports.  

This bill requires the state Department of Health and Senior Services (DHSS) to provide more than $2 million in grants for the research, subject to lawmakers approving the appropriation. The state would collaborate on the study with a Missouri university hospital or medical center operated by the U.S. Department of Veterans Affairs in Missouri.   

In June, Miriam E. Delphin-Rittmon, assistant secretary for mental health and substance use, wrote to U.S. Rep. Madeleine Dean (D-PA) that federal Food and Drug Administration approval of psilocybin to treat depression was likely within the next two years, the report says. However, state Rep. Tony Lovasco (R), who has previously sponsored similar legislation, told the Independent that two years is a long time to wait.

Suicide rates in Missouri are about 25% higher than the national average, the report says, and research suggests psychedelic therapies, such as psilocybin, can be efficacious in treating conditions that may cause individuals to consider committing suicide.

State Rep. Aaron McMullen (R), a combat veteran who served in Afghanistan, said during the debate that “Substance abuse and suicide are escalating in the veterans community.”

“While psilocybin is not a panacea for every issue,” he said, “it represents a first true scientifically-validated hope that we have to address this crisis.”

The legislation still requires approval from the Senate and governor before becoming law. (Full Story)

Next Post

Washington State Psychedelic Therapies Bill Pared Down to Pilot Program

A bill to allow psychedelic therapies in Washington state has stalled, but lawmakers are considering legislation to allow military veterans and first responders to access a pilot program for the treatment, the Seattle Times reports. The pilot program bill has passed the…
Read
Previous Post

Psilocybin services set for Oregon takeoff

The psychedelics movement and its poster child psilocybin are continuing to make waves as adults 21 and older will likely consume the first legal dose of the magic mushroom-derived compound since 1968 this year in Oregon. The research renaissance of…
Read
Random Post

Alabama Medical Cannabis Firm Accuses Regulators of Erasing Meeting Records in Violation of Open Meetings Law

A medical cannabis business applicant is accusing the Alabama Medical Cannabis Commission (AMCC) of improperly erasing recordings of its meetings, AL.com reports. The company says the recordings could include information relevant to its lawsuit against the agency.  The lawsuit by Alabama Always…
Read
Random Post

Massachusetts cannabis cultivator, retailer Insa laying off workers

Massachusetts-based cannabis cultivation and retail company Insa laid off an undisclosed number of workers in the past few months. The downsizing was a result of increased competition from “out-of-state” companies in the Massachusetts marijuana market, Insa CEO Peter Gallagher told MassLive.com via…
Read
Random Post

Congressional Committee Addresses FDA Inaction On CBD Regulations At Hearing

A first-of-its-kind congressional committee hearing took place on Thursday, with lawmakers examining the impacts of Food and Drug Administration (FDA) inaction on developing regulations to allow for the sale of hemp-derived CBD as food items or dietary supplements. The House…
Read
Random Post

New Hampshire Senate Votes Down Cannabis Legalization Bill

The New Hampshire Senate on Thursday voted down the House-approved cannabis legalization bill by a 14-10 margin, the New Hampshire Bulletin reports. The vote was mostly across party lines and came after the chamber’s Judiciary Committee opposed the measure as “inexpedient to legislate.”  Democratic Sen. Lou…
Read